Rare diseases
Investigational molecules
Locations
Study on Nivolumab and Cisplatin for Patients with Metastatic Triple Negative Breast Cancer
The NetherlandsStudy of Ipilimumab and Nivolumab for Patients with Metastatic Castration-Resistant Prostate Cancer
The NetherlandsStudy on Sunitinib and Nivolumab with Chemotherapy for Patients with Advanced Soft Tissue and Bone Sarcomas
ItalyStudy on Continuing Nivolumab and Ipilimumab Treatment vs. Observation in Patients with Stage IV Non-Small Cell Lung Cancer
FranceStudy Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
CroatiaStudy on Pausing Treatment with Pembrolizumab and Axitinib in Patients with Metastatic Kidney Cancer at Good or Intermediate Risk
FranceStudy on Nivolumab with Paclitaxel and Carboplatin for Early Stage Triple Negative Breast Cancer Patients
ItalyStudy on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma
BelgiumStudy on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy
FranceStudy of Visugromab and Nivolumab for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Refuse Cisplatin Chemotherapy
ItalyStudy of Subcutaneous Nivolumab for Patients with Previously Treated Advanced or Metastatic Clear Cell Kidney Cancer
CzechiaStudy of Darovasertib and Crizotinib for Patients with Metastatic Uveal Melanoma Who Are HLA-A2 Negative
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
